Development of crizotinib, a rationally designed tyrosine...

  • Main
  • 2016 / 11
  • Development of crizotinib, a rationally designed tyrosine...

Development of crizotinib, a rationally designed tyrosine kinase inhibitor for non-small cell lung cancer

Poon, Candice C., Kelly, John J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.30533
Date:
November, 2016
File:
PDF, 1.33 MB
english, 2016
Conversion to is in progress
Conversion to is failed